DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.74

EPS Forecast

$11.94

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-12-31
REPLReplimune Group IncNBIXNeurocrine Biosciences IncRGENRepligen CorpHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna IncCRSPCrispr Therapeutics Ag